{"slug":"neoadjuvant","tag":"neoadjuvant","variants":["neoadjuvant"],"description":"No description yet","count":11,"kinds":{"person":11},"related":[{"slug":"melanoma","tag":"melanoma","shared":3},{"slug":"surgery","tag":"surgery","shared":3},{"slug":"immunotherapy","tag":"immunotherapy","shared":2},{"slug":"lung","tag":"lung","shared":2},{"slug":"australia","tag":"australia","shared":1},{"slug":"braf","tag":"braf","shared":1},{"slug":"breast","tag":"breast","shared":1},{"slug":"glioma","tag":"glioma","shared":1},{"slug":"head-and-neck","tag":"head-and-neck","shared":1},{"slug":"italy","tag":"italy","shared":1},{"slug":"microbiome","tag":"microbiome","shared":1},{"slug":"pancreatic","tag":"pancreatic","shared":1}],"records":[{"id":"tina-cascone","kind":"person","name":"Tina Cascone","route":"/people/tina-cascone/","tldr":"Led CheckMate 77T, one of the perioperative immunotherapy trials that changed how operable lung cancer is treated."},{"id":"jonathan-spicer","kind":"person","name":"Jonathan Spicer","route":"/people/jonathan-spicer/","tldr":"The surgeon on CheckMate 816 who showed neoadjuvant immunotherapy does not make lung cancer operations harder."},{"id":"marc-besselink","kind":"person","name":"Marc G. Besselink","route":"/people/marc-besselink/","tldr":"Dutch surgeon who leads the PREOPANC trials testing chemotherapy or chemoradiation before pancreatic cancer surgery."},{"id":"andrea-necchi","kind":"person","name":"Andrea Necchi","route":"/people/andrea-necchi/","tldr":"Led PURE-01, the first neoadjuvant pembrolizumab trial in bladder cancer, and now leads bladder-preserving immunotherapy studies."},{"id":"georgina-long","kind":"person","name":"Georgina V. Long","route":"/people/georgina-long/","tldr":"Melanoma trialist who led COMBI-d, COMBI-AD and NADINA, moving immunotherapy before surgery for stage III disease."},{"id":"sapna-patel","kind":"person","name":"Sapna P. Patel","route":"/people/sapna-patel/","tldr":"Led SWOG S1801, the trial that showed giving pembrolizumab before surgery, not just after, improves outcomes in melanoma."},{"id":"jennifer-wargo","kind":"person","name":"Jennifer A. Wargo","route":"/people/jennifer-wargo/","tldr":"Surgeon-scientist who showed the gut microbiome shapes response to immunotherapy and led early neoadjuvant melanoma trials."},{"id":"timothy-cloughesy","kind":"person","name":"Timothy F. Cloughesy","route":"/people/timothy-cloughesy/","tldr":"Neuro-oncologist whose neoadjuvant PD-1 trial showed immunotherapy before surgery can activate immune responses in glioblastoma."},{"id":"ravindra-uppaluri","kind":"person","name":"Ravindra Uppaluri","route":"/people/ravindra-uppaluri/","tldr":"Surgeon-scientist who led the first neoadjuvant pembrolizumab trial in head and neck cancer and the KEYNOTE-689 study that made it standard."},{"id":"maria-cabanillas","kind":"person","name":"Maria E. Cabanillas","route":"/people/maria-cabanillas/","tldr":"Turned anaplastic thyroid cancer from a death sentence into a treatable disease with BRAF-targeted therapy and neoadjuvant strategies."},{"id":"luca-gianni","kind":"person","name":"Luca Gianni","route":"/people/luca-gianni/","tldr":"Milan oncologist who led NeoSphere, the trial that showed adding pertuzumab to trastuzumab and docetaxel before surgery clears more HER2-positive breast cancers, the basis for pertuzumab's neoadjuvant approval."}]}